Document is current
Any future updates will be listed below
-
Authors
Croft, Jacob https://orcid.org/0000-0001-7892-0534
Sandoval, Diana F. https://orcid.org/0009-0008-4117-7562
Cistola, David https://orcid.org/0000-0002-9586-8720
Zhang, Jun https://orcid.org/0000-0002-4379-3616
-
Funding
Funding for this research was provided by:
nih (NHLBI 1 R21 HL143030)
- License Information
-
More Information
Article History
Received: 11 August 2023
Accepted: 7 May 2024
First Online: 25 May 2024
Declarations
:
: This study has been approved by the Texas Tech University Health Science Center El Paso Institutional Review Board (IRB) with approved protocol (IRB-E21010).
: Every participant with CCM1 in this study has provided consent in alignment with the protocols established by the local Institutional Review Board (IRB-E21010).
: Not applicable.
: Dr. Cistola is the lead inventor on U.S. and European T<sub>2</sub>-related patents assigned to the Texas Tech University System, University of North Texas Health Science Center, and East Carolina University. The authors declared no other conflicts of interest. Dr. Zhang is the lead inventor on U.S. and PCT Contracting States (The member nations of Patent Cooperation Treaty) CCM biomarkers patents (PCT/US2021/035907-US2023/0228766 A1) assigned to the Texas Tech University System.
